| Title | Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. |
| Publication Type | Journal Article |
| Year of Publication | 2002 |
| Authors | Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJJ |
| Journal | Ann Neurol |
| Volume | 51 |
| Issue | 5 |
| Pagination | 634-7 |
| Date Published | 2002 May |
| ISSN | 0364-5134 |
| Keywords | Adolescent, Adult, Aged, Animals, Blood Platelets, Cardiolipins, Cell Line, Child, Child, Preschool, Dogs, Female, Humans, Infant, Linoleic Acid, Male, Mice, Mice, Inbred C3H, Middle Aged, Mitochondria, Heart, Mitochondrial Myopathies, Muscle, Skeletal, Myocardium, Rats, Rats, Sprague-Dawley |
| Abstract | Barth syndrome is an X-linked cardiac and skeletal mitochondrial myopathy. Barth syndrome may be due to lipid alterations because the product of the mutated gene is homologous to phospholipid acyltransferases. Here we document that a single mitochondrial phospholipid species, tetralinoleoyl-cardiolipin, was lacking in the skeletal muscle (n = 2), right ventricle (n = 2), left ventricle (n = 2), and platelets (n = 6) of 8 children with Barth syndrome. Tetralinoleoyl-cardiolipin is specifically enriched in normal skeletal muscle and the normal heart. These findings support the notion that Barth syndrome is caused by alterations of mitochondrial lipids. |
| DOI | 10.1002/ana.10176 |
| Alternate Journal | Ann. Neurol. |
| PubMed ID | 12112112 |
| Grant List | GM50686 / GM / NIGMS NIH HHS / United States |
Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.